What glucose load (grams) and gestational age are recommended for performing an oral glucose tolerance test (OGTT) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Glucose Tolerance Testing in Pregnancy

Perform gestational diabetes screening at 24-28 weeks of gestation using either a 75-gram oral glucose tolerance test (one-step approach) or a 50-gram glucose challenge test followed by 100-gram OGTT if positive (two-step approach). 1

Timing: When to Test

  • Standard screening window: 24-28 weeks gestation for all pregnant women not previously diagnosed with diabetes 1, 2
  • Early testing (first prenatal visit): Only for high-risk women with marked obesity, personal history of GDM, glycosuria, or strong family history of diabetes 3
    • If negative at early screening, retest at 24-28 weeks 3

Glucose Load: Two Accepted Strategies

One-Step Approach (IADPSG/ADA Recommended)

Use a 75-gram glucose load with measurements at fasting, 1-hour, and 2-hour 1, 2, 4

  • Patient must fast overnight (≥8 hours)
  • GDM diagnosed if any one value meets or exceeds:
    • Fasting: ≥92 mg/dL (5.1 mmol/L)
    • 1-hour: ≥180 mg/dL (10.0 mmol/L)
    • 2-hour: ≥153 mg/dL (8.5 mmol/L)

Two-Step Approach (NIH Consensus)

Step 1: 50-gram glucose challenge test (non-fasting) at 24-28 weeks 1, 5

  • If 1-hour glucose ≥140 mg/dL (some use ≥130 or ≥135 mg/dL), proceed to Step 2

Step 2: 100-gram OGTT (fasting) 1, 5

  • GDM diagnosed if at least two values meet or exceed (Carpenter/Coustan criteria):
    • Fasting: ≥95 mg/dL (5.3 mmol/L)
    • 1-hour: ≥180 mg/dL (10.0 mmol/L)
    • 2-hour: ≥155 mg/dL (8.6 mmol/L)
    • 3-hour: ≥140 mg/dL (7.8 mmol/L)

Key Clinical Considerations

Both approaches are endorsed by major guidelines, though they identify different populations 1, 2. The one-step 75-gram approach diagnoses more women with GDM (lower thresholds, only one abnormal value needed), while the two-step approach is more specific but requires two visits for those who screen positive.

Common pitfall: Testing too early (before 24 weeks) in average-risk women lacks evidence for benefit and may miss cases that develop later 6. Research shows glucose values and diagnostic thresholds differ between early and late pregnancy 7, 8.

For high-risk ethnic populations (Native American, Hispanic, Asian), ACOG recommends a lower screening threshold of 135 mg/dL or even 130 mg/dL for the 50-gram challenge test 1.

The choice between one-step and two-step approaches depends on your practice setting, patient population prevalence of GDM, and resource availability, but the 24-28 week timing is non-negotiable for standard screening 1, 6, 2.

References

Related Questions

In a pregnant woman with a normal oral glucose tolerance test (OGTT) at 23 weeks gestation, is a repeat OGTT required between 24 and 28 weeks?
How should the oral glucose challenge test (OGCT) be performed and interpreted in a pregnant woman at 24–28 weeks gestation?
What is the immediate management of acute hypoglycemia in a 55-year-old man with type 2 diabetes mellitus on insulin who skipped breakfast and presents with a capillary glucose of 42 mg/dL, pale, sweaty, tachycardic, and confused?
What is the clinical significance of a +1 glucose result on a urine dipstick and how should it be evaluated?
During a 100‑gram oral glucose tolerance test, my 180‑minute glucose level was 39 mg/dL, yet my home glucose measurements are within normal limits—what does this finding indicate and how should it be managed?
How should anticoagulation be managed in a patient with mesenteric venous thrombosis who has no history of trauma or infection?
In a 45‑year‑old woman with severe vasomotor symptoms refractory to a 0.0375 mg transdermal estradiol patch, iron deficiency after gastric bypass, anxiety, and worsening migraine, may I increase the estradiol patch to the next available strength (0.05 mg), add low‑dose vaginal estradiol cream for dryness, and how should I manage her anxiety and migraine while initiating sertraline?
What is the appropriate treatment for a 4-year-old child with Salmonella diarrhea?
What are the recommended dosing, contraindications, side effects, and monitoring guidelines for modafinil in an adult?
After transfusing one unit of packed red blood cells in an adult, should I give 20 mg furosemide intravenously or 10 mg intravenously?
Can lamotrigine be increased from 250 mg to 300 mg after two weeks of therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.